Breaks Categories: Stock Spotlights

ThursdayOct 10, 2019 2:57 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Takes Aim at National Hemp-Derived CBD Market Forecasted to Reach $7 Billion by 2023

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal for the global Chinese-speaking community, recently attended the MicroCap Conference at the Essex House in New York. CIIX subsidiary Biotech CBD Inc. CFO Alex Hamilton gave the company’s presentation (http://cnw.fm/x5iZm). An article discussing the company reads, “The conference was designed to bring together high-level institutional and retail investors with publicly held small- and micro-cap companies. Wang noted that he is optimistic about the long-term growth of CBD sales and said that, moving forward, the company plans to focus on cosmetics in the category. According to New Frontier Data, the U.S.…

Continue Reading

ThursdayOct 10, 2019 2:48 pm

CBDNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroShear K45 System Creates Water-Soluble CBD Oil

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, has developed a revolutionary CBD processing system, the BaroShear K45, which effectively solves the water solubility issue found in most of today’s oil-based CBD products. An article discussing the company reads, “Development of the BaroShear K45 system began following the company’s in-depth analysis of the CBD market, which showed a common, yet critical production issue facing CBD manufacturers – the poor water solubility of today’s oil-based CBD products means that the beneficial properties of…

Continue Reading

WednesdayOct 09, 2019 3:06 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Establishes New CBD Sales Division Concentrating on Therapeutic, Pharmaceutical-Grade Products

Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, recently established a new sales division focusing specifically on CBD for therapeutic and pharmaceutical-grade products. An article discussing the company reads, “The impetus behind this new division comes from increased interest in CBD products across multiple medical communities, including medical, holistic and alternative medicine (http://cnw.fm/4c6Se). The division will be headed by Erika Franck, who has been serving as the company’s clinical and therapeutics sales director for several weeks. In her new role, Franck will be working with medical providers, chiropractors, acupuncturists, holistic-wellness practitioners and veterinarians, utilizing her years of experience in the…

Continue Reading

FridayOct 04, 2019 3:14 pm

CBDNewsBreaks – VPR Brands LP (VPRB) Offers Robust Suite of Products in Nicotine, CBD Verticals

VPR Brands (OTCQB: VPRB) has developed of a suite of brands for the nicotine and CBD (cannabidiol) markets. An article discussing the results reads, “VPR Brands expects to launch a second CBD brand — Dr. Good Hemps — into the marketplace this year. The company is concentrating on cannabis consumables, focusing on leveraging the numerous opportunities available in this space. With major regulatory shifts toward the CBD vertical, the market is forecast to grow to an estimated $22 billion by 2022 (http://cnw.fm/rL0in). . . .  VPR Brands offers a compelling investment opportunity for investors looking for exposure to the nicotine and…

Continue Reading

ThursdayOct 03, 2019 3:17 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Holds Prominent Position as Cannabis Biotech Sector Continues to Evolve

Earth Science Tech (OTCQB: ETST) is an innovative biotechnology company that manufactures 100% natural CBD oil using the supercritical CO2 liquid extraction. An article discussing the company reads, “With biotech being the largest sector of the legal cannabis market (http://cnw.fm/6B4cR), ETST appears ideally poised to be a key player in the burgeoning space. . . . Brightfield Group, a leading market and consumer intelligence firm for the legal cannabinoids and cannabis industries, recently reported that the U.S. CBD market was projected to see an unprecedented 700% growth through 2019 (http://cnw.fm/Ra2EU). With hemp-derived CBD increasingly being used in health, wellness and anti-pharma…

Continue Reading

ThursdayOct 03, 2019 3:02 pm

CBDNewsBreaks – Neutra Corp. (NTRR) Strengthens CBD Retail Market Position with Recent Acquisition

Early-stage research and development company Neutra Corp. (OTCQB: NTRR) on Sept. 10 announced the completion of its acquisition of VIVIS Corp., an emerging retail brand of hemp-based wellness and health products (http://cnw.fm/UXjo0). A recent article discussing the interview reads, “‘VIVIS gives us an up-and-coming retail brand that’s gaining a solid market standing for quality, potency and customer satisfaction. With the respected VIVIS name on Neutra’s CBD products, we expect to gain a strong foothold in the hemp-based CBD market,’ Neutra President Sydney Jim said in a news release. . . . One of the biggest distinctions between VIVIS products and…

Continue Reading

WednesdayOct 02, 2019 2:47 pm

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation

HTC Extraction Systems (TSX.V: HTC), a gas, liquids and biomass extractor and refiner, recently reported financial results for the second quarter and six-month period ending June 30, 2019 (http://cnw.fm/t2btS). An article discussing the company reads, “HTC Extraction Systems recorded an increase in same-period, year-over-year revenues from operations during the first six months of 2019, rising from $560,260 to $1.85 million, according to unaudited interim condensed consolidated financial results. . . . HTC and its subsidiaries are dedicated to developing their proprietary extraction and purification systems for removing cannabidiol full-spectrum oil (CBD FSO) distillate from acquired hemp biomass and making the remaining hemp…

Continue Reading

FridaySep 27, 2019 2:32 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Focusing on CBD-Based Nutrition, Health Products

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX), through its division CBD Biotech Inc., is concentrating on cannabidiol (CBD)-based nutrition and health products. An article discussing the company reads, “CIIX recently announced that CBD Biotech launched six new products in combination with its long-term strategic plans to expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear Bright. These products are designed to complement the company’s present skincare…

Continue Reading

ThursdaySep 26, 2019 2:49 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Plans to Expand Reach of Distinctive 100% Natural CBD Oil

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) manufactures 100% natural CBD oil using the supercritical CO2 liquid extraction, isolation and micron-filtration process. An article discussing the company reads, “ETST recently filed a 10-K annual report with the SEC that included an outline of the company’s five-year expansion plan for manufacturing and marketing its CBD products (http://cnw.fm/z6FOm). The plan includes information about the company’s strategic preparations to scale up the production of its CBD oil, introduce new products and make its innovative hemp products available worldwide (http://cnw.fm/7gI5w). . . . ‘Our CBD-rich hemp oil does not contain any synthetic cannabinoids and is…

Continue Reading

ThursdaySep 26, 2019 2:42 pm

CBDNewsBreaks – Neutra Corp. (NTRR) Targets Hemp-Based CBD Market

Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, is aiming to participate in the hemp-based CBD market through its recent strategic acquisition of Vivis Corp. A recent article discussing the interview reads, “The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49%, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://cnw.fm/6MJmx). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries. . . . Neutra Corp.’s previously announced acquisition…

Continue Reading